Cision PR Newswire

Fly-E Group, Inc. Announces Second Quarter and First Half of Fiscal Year 2027 Financial Results

NEW YORK, Nov. 14, 2026 /PRNewswire/ -- Fly-E Group, Inc. (Nasdaq: FLYE) ("Fly-E" or the "Company"), an electric vehicle company engaged in designing, installing, selling, and renting smart electric motorcycles, electric bikes, and electric scooters, today announced its unaudited financial results for the second quarter and first half of fiscal...

Yiren Digital Receives NYSE Notification Regarding Stock Price Requirement

BEIJING, Nov. 14, 2026 /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or...

Greenland Technologies Holding Corporation Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

HANGZHOU, China, Nov. 14, 2026 /PRNewswire/ -- Greenland Technologies Holding Corporation (Nasdaq: GTEC) ("Greenland"...

FiEE, Inc. Announces Third Quarter 2026 Unaudited Financial Results

Revenue for the First Nine Months of 2026 Surged 382.1% Year-on-Year to Approximately $9.6...

Gene Solutions and Pangea Laboratory Establish Strategic Collaboration to Validate Laboratory Developed ctDNA Tests for Precision Screening and Cancer Care in the U.S.

IRVINE, Calif., Jan. 21, 2026 /PRNewswire/ -- Gene Solutions, a global biotechnology company, and Pangea Laboratory, a CLIA-certified, CAP-accredited Next Generation Sequencing (NGS) leader...

ChooChoo, an AI Interactive Reading Toy Built on RiseLink Edge Intelligence, Featured at CES 2026 and Highlighted Across National and Local Media

LAS VEGAS, Jan. 21, 2026 /PRNewswire/ -- ChooChoo, an AI-powered interactive reading companion designed to support early childhood language development, was featured at CES®...

Insilico Medicine and Hygtia Therapeutics Enter New Global Strategic Collaboration to Co-Develop Novel Brain Penetrant NLRP3 Inhibitor for CNS Diseases treatment

Insilico Medicine and Hygtia Therapeutics, an incubatee of Shenzhen Pengfu Fund of Fosun Health Capital and Fosun Pharma, have entered into...